2025 - Cancer Currents Blog
-
A subgroup of mesenchymal stem cells, called high-risk MSCs, appears to fuel the formation of cancerous lesions in the fallopian tubes and the lesions’ transition to ovarian cancer, a study has found.
-
In small trials, personalized treatment vaccines appeared to prevent cancer from returning in patients who had successful surgery to remove their tumors. The treatments, which were created based on intensive analyses of patients’ tumors, appeared to be safe.
-
Documented conversations on goals of care are uncommon in AYA patients with advanced cancer. Researchers found that many patients did not have these discussions until the last month of life, and many asked about palliative care.
-
Some cancers come back many years after successful treatment, often as metastatic disease. Researchers believe if and how this happens is heavily influenced by dormant cancer cells and their interaction with the immune system.